FMO2 · Western blot design guide

FMO2 Western Blot Planning Guide

Plan a FMO2 Western blot around the catalog-observed 63.3 kDa band, image-backed PB9760 evidence, HPA controls, and verified protocol records.

Evidence assembled July 2026 · For research use; verify linked source records and product datasheet before use
Western blot protocol sheet for FMO2 (FMO2): expected band 63.3 kDa, antibody PB9760, and PMC-cited SDS-PAGE protocol steps
FMO2 Western blot protocol sheet — expected band 63.3 kDa, antibody PB9760, controls and PMC citations. Open the full FMO2 WB guide →

FMO2 Western Blot Experimental Design Guide

Expected bands, documented protocol parameters, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band 63.3 kDa
Observed band Not reported — verify product WB image
Gel 12-15%
Positive control ⓘ Breast
Negative control ⓘ Bone marrow
Important caveats
Reasons your observed band may differ from the expected size.
ⓘ Calculated mass 63.3 kDa
ⓘ Localization Microsome membrane / Endoplasmic reticulum membrane
ⓘ Processing / PTM Record-dependent
ⓘ Reactivity Human / Mouse / Rat
Section 1

Real Curated FMO2 Western Blot Protocols

Start with the molecular-weight rule, then compare verified publication-derived conditions.

Recommended Western blot protocol parameters
Sample / lysateAdrenal gland
Gel %12-15%
Load20-30 µg total protein per lane
TransferSemi-dry, standard transfer
Membrane0.45 µm PVDF
Blocking5% non-fat milk or 5% BSA in TBST
PrimaryPB9760 at datasheet starting dilution
Primary incubationOvernight at 4 °C with gentle agitation
SecondarySpecies-matched HRP conjugate at validated dilution
Wash3 × 5 min in TBST
DetectionChemiluminescent substrate
ExposureBracket exposures to avoid saturation
Section 2

What Is the Expected FMO2 Western Blot Band Size?

Use the product-observed 63.3 kDa band as the primary planning value and retain the UniProt calculated mass as context.

What am I looking at on my blot?
63.3 kDaMatches the authoritative product WB observation.
63.3 kDa calculatedUse as UniProt context, not as a replacement observed band.
Unexpected additional signalDo not assign identity without orthogonal positive/negative controls.
💡Expected FMO2 appearancePlan around 63.3 kDa and keep the calculated mass as supporting context.
How each factor affects band size
Catalog-observed band63.3 kDa; use this as the primary experimental expectation.
Calculated mass63.3 kDa from UniProt P31512; retain as context.
Gel selection12-15%; shared with the recommended protocol and poster.
Specificity checkCompare the lead HPA positive and negative controls with PB9760.
Why is my band missing or off?
SituationLikely causeNext action
63.3 kDaMatches the authoritative product WB observation.Confirm with orthogonal controls and the linked product record.
Additional bandMay reflect processing, modification, or non-specific signal.Run a dilution series and compare positive/negative controls.
Weak signalTarget abundance or transfer may be limiting.Verify transfer, increase positive-control abundance, and bracket exposure.

Sample controls for FMO2 Western blot

🧪Use Breast as the first positive-control candidate and Bone marrow as the HPA Not detected negative candidate.
Positive control: Breast (Medium)
Negative control: Bone marrow (Not detected)
HPA protein score determines control status; other expression data is supporting context only.

HPA tissue expression evidence for FMO2

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.

Positive expression · recommended positive controls

TissueCell typeLevelEvidenceSource
Breast Reported tissue cells Medium Protein (HPA) HPA →
Adrenal gland Reported tissue cells Medium Protein (HPA) HPA →
Caudate Reported tissue cells Medium Protein (HPA) HPA →
Appendix Reported tissue cells Medium Protein (HPA) HPA →

Undetected expression · recommended negative controls

TissueCell typeLevelEvidenceSource
Bone marrow Reported tissue cells Not detected Protein (HPA) HPA →
Lymph node Reported tissue cells Not detected Protein (HPA) HPA →
Section 3

Advanced FMO2 Western Blot Tips

Deeper troubleshooting and optimisation questions for FMO2, answered from its protein features.

Which band should guide the blot?
Use 63.3 kDa, the observation attached to the authoritative PB9760 WB record.
How should calculated mass be interpreted?
Treat the UniProt calculated mass as context; it does not replace the catalog-observed 63.3 kDa expectation.
Which positive control should I start with?
Start with Breast, the lead HPA protein-expression candidate.
Which negative control is defensible?
Use Bone marrow as an orthogonal HPA Not detected candidate.
Which gel should I use?
Use 12-15% consistently across the quick facts, protocol table, and poster.
What transfer method to use for FMO2 Western blot?
Use the transfer method in the recommended protocol and verify transfer before blocking.
How should PB9760 be started?
Start at the linked datasheet condition and run a three-point primary-antibody dilution test.
Which publication-derived protocols can I compare?
Compare only the supplied target-verified records: PMC10558214, PMC12381804, PMC13403412.
Boster reagents

FMO2 Western Blot Reagents

Human/Mouse/Rat-reactive FMO2 Western blot reagents with authoritative product imagery.

Real WB data Western blot validation image for FMO2 using PB9760; observed band 63.3 kDa
Anti-FMO2 Antibody Picoband®
Cat # PB9760

Only image-backed, WB-validated Human/Mouse/Rat recommendations from the prepared catalog evidence are shown.

Source: prepared picoband-wb product evidence; each card retains its own SKU, URL, observed band, and authoritative WB image.